Literature DB >> 1380929

Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects.

J Martineau1, C Barthélémy, J Jouve, J P Muh, G Lelord.   

Abstract

Levels of dopamine (DA) and its derivatives homovanillic acid (HVA), 3-4 dihydroxyphenylacetic acid (DOPAC), 3-methoxytyramine (3MT) and norepinephrine+epinephrine (NE + E), and serotonin (5HT) and its derivative 5-hydroxyindolacetic acid (5HIAA) were determined from the urine of 156 autistic children aged two to 12 years 6 months, and compared with those of age-matched mentally retarded non-autistic and normal controls. Very significant group and age effects were found for DA, HVA, 3MT, NE + E and 5HT. High HVA, 3MT, NE + E and 5HT levels were found in autistic and non-autistic children. The DA, HVA, 3MT, NE + E, 5HT and 5HIAA levels decreased significantly with age in the three groups. Significantly decreased levels of DA and HVA were observed in autistic children on haloperidol, compared with non-medicated autistic children. The results are discussed in relation to the hypothesis of a maturation defect of monoaminergic systems in autism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380929     DOI: 10.1111/j.1469-8749.1992.tb11490.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  17 in total

Review 1.  The neurobiology of autism: new pieces of the puzzle.

Authors:  Maria T Acosta; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

2.  Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder.

Authors:  Christa J Anderson; John Colombo; Kathryn E Unruh
Journal:  Dev Psychobiol       Date:  2012-05-29       Impact factor: 3.038

Review 3.  Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Authors:  Logan K Wink; Martin H Plawecki; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

Review 4.  Etiology of infantile autism: a review of recent advances in genetic and neurobiological research.

Authors:  G Trottier; L Srivastava; C D Walker
Journal:  J Psychiatry Neurosci       Date:  1999-03       Impact factor: 6.186

5.  Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury.

Authors:  M Dennis; L Lockyer; A L Lazenby; R E Donnelly; M Wilkinson; W Schoonheyt
Journal:  J Autism Dev Disord       Date:  1999-02

6.  Investigation of whole blood and urine monoamines in autism.

Authors:  Josiane Hérault; Joëlle Martineau; Anne Perrot-Beaugerie; Jacqueline Jouve; Hervé Tournade; Catherine Barthelemy; Gilbert Lelord; Jean-Pierre Muh
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-10       Impact factor: 4.785

7.  Brief report: Platelet-poor plasma serotonin in autism.

Authors:  George M Anderson; Margaret E Hertzig; P A McBride
Journal:  J Autism Dev Disord       Date:  2012-07

8.  Elevated dopamine levels during gestation produce region-specific decreases in neurogenesis and subtle deficits in neuronal numbers.

Authors:  Deirdre McCarthy; Paula Lueras; Pradeep G Bhide
Journal:  Brain Res       Date:  2007-09-21       Impact factor: 3.252

Review 9.  The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.

Authors:  David Q Beversdorf
Journal:  Semin Pediatr Neurol       Date:  2020-06-24       Impact factor: 1.636

10.  Dopaminergic hypo-activity and reduced theta-band power in autism spectrum disorder: A resting-state EEG study.

Authors:  Taylor Hornung; Wen-Hsuan Chan; Ralph-Axel Müller; Jeanne Townsend; Brandon Keehn
Journal:  Int J Psychophysiol       Date:  2019-10-24       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.